2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine
C117H134N42O9 — CID 157096404
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine
2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine (PubChem CID 157096404) has the molecular formula C117H134N42O9 and a molecular weight of 2272.64 g/mol. Its IUPAC name is 2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine.
Molecular Properties
| Compound Name | 2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine |
|---|---|
| PubChem CID | 157096404 |
| Molecular Formula | C117H134N42O9 |
| Molecular Weight | 2272.64 g/mol |
| Exact Mass | 2271.13 |
| IUPAC Name | 2-[4-[3-[(2R)-2-[6-(6-amino-3-pyridinyl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;2-[[5-[3-[(2R)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazin-2-yl]-methylamino]ethanol;1-[4-[3-[(2S)-2-[6-(2-aminopyrimidin-5-yl)-3-pyridinyl]-3-methylbutan-2-yl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]butan-2-one;5-[5-[(1R)-1-cyclopropyl-1-[5-(5-piperazin-1-ylpyrazin-2-yl)-1,2,4-oxadiazol-3-yl]ethyl]-2-pyridinyl]pyrimidin-2-amine;5-[5-[(2R)-2-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl]-2-pyridinyl]pyridin-2-amine |
| SMILES | CC(C)[C@](C)(c1ccc(-c2ccc(N)nc2)nc1)c1noc(-c2cnn(CC(=O)N(C)C)c2)n1.CC(C)[C@](C)(c1ccc(-c2cnc(N)nc2)nc1)c1noc(-c2cnc(N(C)CCO)cn2)n1.CCC(=O)Cn1cc(-c2nc([C@](C)(c3ccc(-c4cnc(N)nc4)nc3)C(C)C)no2)cn1.COCCn1cc(-c2nc([C@@](C)(c3ccc(-c4ccc(N)nc4)nc3)C(C)C)no2)cn1.C[C@@](c1ccc(-c2cnc(N)nc2)nc1)(c1noc(-c2cnc(N3CCNCC3)cn2)n1)C1CC1 |
| InChI | InChI=1S/C24H26N10O.C24H28N8O2.C23H27N9O2.C23H26N8O2.C23H27N7O2/c1-24(16-2-3-16,17-4-5-18(27-12-17)15-10-30-23(25)31-11-15)22-32-21(35-33-22)19-13-29-20(14-28-19)34-8-6-26-7-9-34;1-15(2)24(3,18-7-8-19(26-12-18)16-6-9-20(25)27-10-16)23-29-22(34-30-23)17-11-28-32(13-17)14-21(33)31(4)5;1-14(2)23(3,16-5-6-17(25-11-16)15-9-28-22(24)29-10-15)21-30-20(34-31-21)18-12-27-19(13-26-18)32(4)7-8-33;1-5-18(32)13-31-12-16(10-28-31)20-29-21(30-33-20)23(4,14(2)3)17-6-7-19(25-11-17)15-8-26-22(24)27-9-15;1-15(2)23(3,18-6-7-19(25-13-18)16-5-8-20(24)26-11-16)22-28-21(32-29-22)17-12-27-30(14-17)9-10-31-4/h4-5,10-14,16,26H,2-3,6-9H2,1H3,(H2,25,30,31);6-13,15H,14H2,1-5H3,(H2,25,27);5-6,9-14,33H,7-8H2,1-4H3,(H2,24,28,29);6-12,14H,5,13H2,1-4H3,(H2,24,26,27);5-8,11-15H,9-10H2,1-4H3,(H2,24,26)/t2*24-;3*23-/m11101/s1 |
| InChIKey | AFGKIBOWSVYTMM-ZOJQLZGESA-N |
| XLogP | 14.35 |
| TPSA | 682.64 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2272.64 |
| LogP ≤ 5 | 14.35 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 50 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157096404 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.